Learning points
Janna Goldfeld, PA-C Janna Goldfeld, PA-C, is a nationally board-certified Physician Assistant with more than 20 years of experience in family medicine, internal medicine, ENT, general surgery, and bariatric/weight loss care
Over a year, she said she lost 80 pounds, which shes been able to keep off
Liraglutide (Saxenda) is specifically contraindicated in inflammatory bowel disease, whilst semaglutide (Wegovy) requires caution in severe gastrointestinal conditions due to overlapping side effects and potential complications
The denominator (total users) isn't publicly available, which means you can't calculate a per-user risk from these figures
Our guide covers the similarities and differences between Wegovy, Ozempic and Mounjaro (another similar weight loss injection)